KPCB Invests $15 Million in Chinese Biotech Firm Says Source

Reuters -- The Chinese arm of the U.S. venture capital fund Kleiner Perkins Caufield & Byers, has invested in a biotechnology firm in eastern China for $15 million, a source with direct knowledge of the matter said on Wednesday.